Khaitan & Co advised India Resurgence Fund on the deal.India Resurgence Fund completed the acquisition of active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS)…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
